Favourable pregnancy outcome after administration of a long-acting gonadotrophin-releasing hormone agonist in the mid-luteal phase.
Administration of a long-acting gonadotrophin-releasing hormone (GnRH) agonist in early pregnancy before implantation took place is reported. Pregnancy outcome was favourable. The possible luteolytic and teratogenic influences of GnRH agonists are discussed.
Weissman
A
A
Department of Obstetrics and Gynaecology, Kaplan Hospital, Rehovot, Israel.
Shoham
Z
Z
D000328:Adult; D006063:Chorionic Gonadotropin / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human; D005260:Female; D006801:Humans; D008183:Luteal Phase; D007986:Luteinizing Hormone / Q000097:blood; D010062:Ovulation Induction; D010446:Peptide Fragments / Q000097:blood; D011247:Pregnancy; D011256:Pregnancy Outcome; D017329:Triptorelin Pamoate / Q000009:adverse effects / Q000627:therapeutic use*
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D017329:Triptorelin Pamoate; D007986:Luteinizing Hormone